共 50 条
- [45] Rifampicin for Continuation Phase Tuberculosis Treatment in Uganda: A Cost-Effectiveness Analysis PLOS ONE, 2012, 7 (06):
- [48] WILL COST-EFFECTIVENESS ANALYSIS WORSEN THE COST-EFFECTIVENESS OF HEALTH-CARE INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1988, 18 (01): : 1 - 9